Aktie A1W1KK CYTOKINETICS, INCORPORATED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Cytokinetics, Incorporated

Aktien

A1W1KK

US23282W6057

CYTK

Markt geschlossen - Nasdaq
Andere Börsenplätze
 21:59:52 30.05.2024 		% 5 Tage % 1. Jan.
49.08 USD +2.55% Intraday Chart für Cytokinetics, Incorporated +0.20% -41.21%
29.05. CYTOKINETICS, INCORPORATED : Truist Securities behält seine Kaufempfehlung bei ZM
28.05. Cytokinetics schließt $500 Millionen Aktienangebot ab MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Cytokinetics to Participate in June Investor Conferences
Cytokinetics Closes $500 Million Stock Offering
Cytokinetics Announces Closing of Public Offering of Common Stock
Cytokinetics, Incorporated announced that it has received $49.999992 million in funding from Royalty Pharma Development Funding, LLC
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday
Nvidia Earnings Fuel Investor Optimism, Driving Premarket Gains for US Equity Futures
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Tech Stocks Rally on NVIDIA Earnings
Stocks in motion: e.l.f Beauty soars along with Nvidia
Top Premarket Decliners
Cytokinetics Prices $500 Million Common Stock Offering
Cytokinetics Announces Pricing of Public Offering of Common Stock
Cytokinetics, Royalty Pharma Unveil up to $575 Million Funding to Advance Research Pipeline
Cytokinetics Plans $500 Million Common Stock Offering -- Shares Drop After Hours
Cytokinetics Announces Proposed Public Offering of Common Stock
Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
Cytokinetics, Incorporated announced that it has received $49.999992 million in funding from Royalty Pharma plc
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
Cytokinetics, Incorporated Announces Resignation of Sandford D. Smith as Board of Directors
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1W1KK Aktie
  4. Nachrichten Cytokinetics, Incorporated
  5. Andere Sprachen